- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07594730
Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems
RCT of Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems
The goal of this study is to test the efficacy of brief video interventions parental internalized stigma and stigma-related outcomes (e.g., treatment intentions, caregiver burden, secrecy) among parents (ages 25-50) of children ages 6-18 with depression, ADHD, or substance use problems.
Timely identification and treatment of mental health problems in youth is a public health priority. However, many youth do not receive treatment, and stigma has been identified as the primary barrier to help-seeking. Parents experience stigma related to their children having mental health problems, which has been associated with reduced help-seeking and increased parental distress. Prior experiments have found brief video-based interventions (BVIs), 1-2 minute videos similar to those viewed by youth on social media platforms, based on the principle of "social contact" with individuals affected by a stigmatized condition, effective in reducing mental health stigma and increasing help-seeking.
In this 4-arm RCT, the investigators will recruit parents aged 25-50 using an online crowdsourcing platform, to test the efficacy of BVIs featuring a personal parent narrative of their experience with their child's a) depression, b) ADHD, or c) substance use, or d) a control condition that provides general written psychoeducational information without social contact.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Brief video-based interventions (BVIs) have been studied as a means of reducing stigma toward mental health problems and increasing help-seeking. "Contact-based interventions," in which a representative of a stigmatized group shares their personal stories, have been found one of the most effective anti-stigma interventions. Effective contact-based interventions target to a specific population, account for the specific interests of that population, and credibly provide stories that highlight recovery in a plausible manner to moderately disconfirm stereotypes. BVIs package contact-based stigma interventions into short (1-2 minute) messages in the style of social media content. Prior RCTs have tested BVIs targeting depression-related stigma in adolescents, featuring a young person describing experiences with depressive symptoms, that improved as they sought support from parents and professionals. Parents often experience stigma to their children's mental health problems and play a critical gate-keeping role for children accessing mental health treatment. Additionally, parental stigma is associated with child mental health outcomes, and potential mediators between parental stigma and child outcomes including parental wellbeing, attitudes toward the child, help-seeking, and self-efficacy. Thus, the investigators hypothesize that BVIs targeted to parents of children with similar mental health conditions (e.g., depression, ADHD, or substance use) will have greater impact on reducing stigma and increasing treatment intentions than generic written psychoeducational content without a social contact component.
This study will measure distinct stigma-related outcomes relevant to parents of children with mental health problems:
- Parental internalized stigma
- Treatment intentions
- Treatment engagement
- Attitudes toward the child
- Caregiver burden
- Self-efficacy
- secrecy coping (i.e., to avoid potential negative repercussions of stigma).
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Doron Amsalem, MD
- Numero di telefono: 929-404-8802
- Email: doron.amsalem@nyspi.columbia.edu
Backup dei contatti dello studio
- Nome: Timothy Becker, MD
- Numero di telefono: 914-997-5203
- Email: tdb2143@cumc.columbia.edu
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10032
- Columbia University Irving Medical Center
-
Contatto:
- Doron Amsalem, MD
- Numero di telefono: 929-404-8802
- Email: doron.amsalem@nyspi.columbia.edu
-
Contatto:
- Timothy Becker, MD
- Numero di telefono: 914-997-5203
- Email: tdb2143@cumc.columbia.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Self-identify as English Speaking
- Live in the US
- Ages 25-50
- Have a child 6-18 years old with either depression, ADHD, or a substance use problem
Exclusion Criteria:
- Do not speak English
- Do not live in the US
- <25 or >50
- Do not have a child between ages 6-18 with depression, ADHD, or a substance use problem
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental: Depression social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's depression, impact of the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Sperimentale: Experimental: ADHD social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's ADHD, impact on the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Sperimentale: Experimental: substance use social contact brief video
Novel brief video (1-2 mins) in which a mother talks about their child's depression, impact on the parent, how parent helped support recovery
|
Brief video about depression (arm 1), ADHD (arm 2), or substance use (arm 3)
|
|
Nessun intervento: Control
Written psychoeducational information about children's mental health, treatment options, and how parents can support child
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Parental Internalized Stigma of Mental Illness scale (PISMI)
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
Measures internalized stigma among parents of children with mental health problems; scores range 12-48; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form (adapted)
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
3-item measure of treatment intentions, modified for parents of children with mental health problems; scores range 0-9; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Zarit Burden Interview screen
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
Brief measure of caregiver burden; scores range 0-16; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Secrecy coping scale (adapted)
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
Parental attitudes toward concealing the child's problems from others; scores range 4-24; higher scores indicate worse outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Parental self-efficacy
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
Single item measure from Parenting sense of competence (PSOC) scale; scores range 1-6; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Parental attitudes and responses toward adolescent depression (adapted)
Lasso di tempo: Immediately after viewing video, 30 days after intervention
|
Select items measuring critical and supportive responses to child's emotional needs; scores range 0-32; higher scores indicate better outcomes
|
Immediately after viewing video, 30 days after intervention
|
|
Treatment engagement
Lasso di tempo: 30 days after intervention
|
3 questions about considering treatment, taking steps to start treatment, or starting treatment in the prior 30 days; yes/no categorical responses - no minimum or maximum values
|
30 days after intervention
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Doron Amsalem, MD, Columbia University; New York State Psychiatric Institute
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Disordini mentali
- Sintomi comportamentali
- Disturbi indotti chimicamente
- Disturbi del neurosviluppo
- Stress, Psicologico
- Disturbi da deficit di attenzione e comportamento dirompente
- Comportamento
- Comportamento sociale
- Onere del caregiver
- Disturbi Correlati a Sostanze
- Disturbo da deficit di attenzione con iperattività
- Stigma sociale
- Comportamento di ricerca di aiuto
Altri numeri di identificazione dello studio
- AAAV7555
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .